These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12358845)
21. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation. Barocci S; Valente U; Nocera A Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591 [TBL] [Abstract][Full Text] [Related]
22. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays. Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819 [TBL] [Abstract][Full Text] [Related]
23. Analysis of Pregnancy-Induced Anti-HLA Antibodies Using Luminex Platform. Vilches M; Nieto A Transplant Proc; 2015 Nov; 47(9):2608-10. PubMed ID: 26680049 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive assessment of sensitizing events and anti-HLA antibody development in women awaiting kidney transplantation. Picascia A; Grimaldi V; Sabia C; Napoli C Transpl Immunol; 2016 May; 36():14-9. PubMed ID: 27013139 [TBL] [Abstract][Full Text] [Related]
25. Role of crossmatch testing when Luminex-SAB is negative in renal transplantation. Jayant K; Reccia I; Julie BM; Sharma A; Halawa A Pol Przegl Chir; 2018 Feb; 90(1):41-46. PubMed ID: 29513250 [TBL] [Abstract][Full Text] [Related]
27. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG. Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446 [TBL] [Abstract][Full Text] [Related]
28. Detection of HLA-specific IGG antibodies using single recombinant HLA alleles: the MonoLISA assay. Barnardo MC; Harmer AW; Shaw OJ; Ogg GS; Bunce M; Vaughan RW; Morris PJ; Welsh KI Transplantation; 2000 Aug; 70(3):531-6. PubMed ID: 10949199 [TBL] [Abstract][Full Text] [Related]
29. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890 [TBL] [Abstract][Full Text] [Related]
30. [Cytotoxicity of natural anti-HLA antibodies in Moroccan patients awaiting for kidney transplantation]. Benseffaj N; Ouadghiri S; Bourhanbour AD; Zerrouki AN; Essakalli M Nephrol Ther; 2017 Feb; 13(1):26-29. PubMed ID: 27914916 [TBL] [Abstract][Full Text] [Related]
31. Flow cytometric detection of complement-activating HLA antibodies. Schönemann C; Lachmann N; Kiesewetter H; Salama A Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206 [TBL] [Abstract][Full Text] [Related]
32. The Most Common HLA Alleles and Anti-HLA Antibodies to Know for Virtual Cross-Match. Baştürk B; Kantaroğlu B; Kavuzlu M; Sarıtürk Ç Exp Clin Transplant; 2016 Nov; 14(Suppl 3):53-55. PubMed ID: 27805512 [TBL] [Abstract][Full Text] [Related]
33. Characterization of patient antibodies after kidney transplantation. Slavcev A; Lácha J; Sajdlová H; Vítko S; Horcicková M; Stríz I; Ivasková E Ann Transplant; 2001; 6(2):12-5. PubMed ID: 11803610 [TBL] [Abstract][Full Text] [Related]
34. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience. İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205 [TBL] [Abstract][Full Text] [Related]
35. Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report. Schlaf G; Radam C; Wahle A; Altermann WW Transplant Proc; 2012 Jun; 44(5):1442-5. PubMed ID: 22664032 [TBL] [Abstract][Full Text] [Related]
36. A novel strategy for the detection and definition of HLA-specific antibodies in patients awaiting renal transplantation. Worthington JE; Langton A; Liggett H; Robson AJ; Martin S Transpl Int; 1998; 11 Suppl 1():S372-6. PubMed ID: 9665019 [TBL] [Abstract][Full Text] [Related]
37. [METHODS FOR DETECTION OF ANTIBODIES TO HLA ANTIGENS IN PATIENTS AWAITING KIDNEY TRANSPLANTATION AND COMBINED PANCREAS-KIDNEY TRANSPLANTATION]. Ančić M; Maravić B; Radman M; Kovačić V Acta Med Croatica; 2014 Dec; 68(4-5):421-3. PubMed ID: 26285477 [TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of anti-HLA antibodies pre and post transplant. Kerman RH; Orosz CG; Lorber MI Am J Med Sci; 1997 May; 313(5):275-8. PubMed ID: 9145036 [TBL] [Abstract][Full Text] [Related]
39. [HLA class I antibody screening and typing in the sera of dialyzed patients with CDC and ELISA techniques: association with graft survival]. Kozma L; Bohaty I Orv Hetil; 2007 Mar; 148(12):553-8. PubMed ID: 17444021 [TBL] [Abstract][Full Text] [Related]
40. [Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation]. Delbos F; Cesbron A Transfus Clin Biol; 2017 Sep; 24(3):131-137. PubMed ID: 28757117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]